Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

45.18
Delayed Data
As of Aug 18
 -0.16 / -0.35%
Today’s Change
30.89
Today|||52-Week Range
47.98
+25.99%
Year-to-Date
NVO Regular Dividend: NVO began trading ex-dividend on 08/17/17. A $0.4736 dividend will be paid to shareholders of record as of 08/21/17.

Today’s Trading

Previous close45.34
Today’s open45.17
Day’s range45.08 - 45.31
Volume1,447,308
Average volume (3 months)2,000,300
Market cap$88.9B
Dividend yield2.10%
Data as of 4:02pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.51%
Revenue growth (last year)+3.81%
P/E ratio2.9
Price/Sales5.48
Price/Book17.62

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.35-0.62%
LLYEli Lilly and Co-0.73-0.94%
ABTAbbott Laboratories-0.55-1.12%
GSKGlaxoSmithKline-0.30-0.77%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.59
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts